#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fallopian tube cancer Bronchiectasis Chronic graft versus host disease in liver Amyotrophic lateral sclerosis Bulbospinal muscular atrophy congenital Niemann-Pick disease Chronic graft versus host disease Tourette's disorder Superficial vein thrombosis Adrenoleukodystrophy Arterial tortuosity syndrome Peritoneal mesothelioma malignant Restless legs syndrome Angiosarcoma metastatic Craniopharyngioma More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Basic Information Waldenstrom’s macroglobulinaemia refractory – Treatment Sjogren’s syndrome – Diagnostics Alternating hemiplegia of childhood – Diagnostics Propionic acidaemia – Diagnostics Gaucher’s disease type I – Basic Information Inclusion body myositis – Treatment Rhabdomyosarcoma recurrent – Basic Information Haemophilia – Life with Disease Behcet’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    A/H1N1 INFLUENZA VACCINE Balstilimab Phosphocreatine Sodium SEVUPARIN Mva-209-Fsp-B2 Pravastatin Sodium Gallium (68Ga) Chloride Nnc0194-0499 [18F]Fapi-74 Goserelin Acetate Itacitinib Guselkumab Lumateperone L-LEUCINE Riboflavin Sodium Phosphate Desloratadine Telitacicept Delafloxacin Certolizumab Pegol Keto-Leucine Calcium More therapies…

    Learn about Your Condition

    Meningioma Cognitive disorder Periarthritis Hyperlipidaemia Procedural headache Gastric cancer stage IV Herpes virus infection Biliary neoplasm Short-bowel syndrome Bronchiectasis Retroperitoneal cancer Kawasaki's disease Meniscus injury Glomerulonephritis Menopausal symptoms More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

    Recruiting

    3 1
    Investigated Diseases:
    • Acute respiratory failure
    Investigated Drugs:
    • Tozorakimab
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study of Itraconazole with Radiotherapy and Temozolomide for Patients with Newly Diagnosed Glioblastoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Itraconazole
    Germany

  • Study on Immunotherapy with HSP-CAR19M and Drug Combination for Adults with B-cell Non-Hodgkin Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • Follicular lymphoma
    • Mantle cell lymphoma
    Investigated Drugs:
    • HSP-CAR19M
    • Cyclophosphamide Monohydrate
    • Fludarabine Phosphate
    Spain

  • Long-term safety study of tulisokibart in adults with Crohn’s disease or ulcerative colitis

    Recruiting

    3 1
    Investigated Drugs:
    • Tulisokibart
    Czechia France Hungary Poland

  • Study on Acoramidis for Preventing Transthyretin Amyloidosis in Young People with a Genetic Risk

    Recruiting

    3 1
    Investigated Diseases:
    • Acquired ATTR amyloidosis
    Investigated Drugs:
    • Acoramidis Hydrochloride
    Belgium Bulgaria Denmark France Germany Greece +6

  • Study comparing Rilvegostomig plus chemotherapy versus Pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Infliximab
    Belgium France Germany Hungary Italy The Netherlands +2
Previous Page
1 … 263 264 265 266 267 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!